Patients Question How FDA Approves Medical Devices
High-profile failures of implantable medical devices â such as certain hip joints and pelvic mesh â have prompted the Food and Drug Administration to revise its assessment process.
The independent source for health policy research, polling, and news.
1,241 - 1,260 of 1,456 Results
High-profile failures of implantable medical devices â such as certain hip joints and pelvic mesh â have prompted the Food and Drug Administration to revise its assessment process.
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHNâs Julie Rovner to discuss the new âMedicare-for-allâ bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHNâs Julie Appleby about the latest âBill of the Monthâ installment.
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHNâs Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
The âMedicareâfor-allâ debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner for a beginnerâs guide to the next big health policy debate. For âextra credit,â the panelists provide their favorite health policy stories of the week, and as a special Valentineâs Day bonus, their favorite #HealthPolicyValentines.
KHN columnist Judith Graham speaks with Sarah Szanton, director of the Center for Innovative Care in Aging at Johns Hopkins School of Nursing, about helping people age with independence.
Health was a featured player in President Donald Trumpâs 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHNâs Julie Rovner to discuss these issues and, for âextra credit,â provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current âBill of the Monthâ feature.
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHNâs Julie Rovner to discuss these issues and take questions from a live studio audience.
âMedicare-for-allâ has become the rallying cry for Democrats in the new Congress. But there is a long list of other ways to increase insurance coverage. Meanwhile, the Trump administration continues to chip away at the Medicaid program for the poor, and new rules could mean higher costs for individual health insurance in 2020. Alice Ollstein of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHNâs Julie Rovner to discuss these issues and, for âextra credit,â provide their favorite health policy stories of the week.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Courtâs abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHNâs Julie Rovner to discuss these issues.
Democratic governors and mayors are unveiling new ideas to control costs and expand coverage. The federal government shutdown has spared most health agencies, but not all. And learn the latest on that lawsuit out of Texas, which is threatening the Affordable Care Act once again. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss these issues and, for âextra credit,â provide their favorite health policy stories of the week. Rovner also interviews KHNâs Jordan Rau about the latest âBill of the Month.â
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents â inspection records, recalls, warning letters and lawsuits â reveals how drugs that are poorly manufactured or contaminated can reach consumers.
On New Yearâs Day, California joined the majority of U.S. states that require people convicted of drunken driving to install ignition-linked breathalyzers in their vehicles. If the devices detect alcohol above a predetermined level, the cars donât start.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listenersâ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHNâs Julie Rovner.
The fallout continues from that Texas court decision that ruled Congressâ 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHNâs Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.
A federal district judge in Texas ruled Friday that Congressâ 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. What happens now? KHNâs Julie Rovner, along with panelists Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post, discuss the bombshell decision and its potential fallout.
Sign-ups for insurance under the Affordable Care Act are still well behind last yearâs mark with just a week until the end of open enrollment in most states. The Supreme Court declines a case that could have allowed states to defund Planned Parenthood. And the Trump administration gets hundreds of thousands of comments about its proposed changes to immigration rules that could penalize people who use government-funded health care and other social service programs. Alice Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss these issues and, for âextra credit,â provide their favorite health policy stories of the week.
Diabetics dying because they canât afford insulin. Organ transplant patients undergoing âwallet biopsiesâ to get on waiting lists. Are out-of-pocket costs going to dominate the health discussion in the next election? Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss this as well as new Trump administration rules giving states the ability to make major changes to the Affordable Care Act. Also, lame-duck lawmakers in Wisconsin and Michigan try to cement health changes before Democrats take over.
Do sales reps in the operating room lend helpful expertise or inflate already bloated costs? Depends on whom you ask.
Š 2026 KFF